Ranked #7,743 of 8,699 institutional investors
Vitruvian Partners LLP
London, X0
$119M
US stock portfolio at live prices · today −$5.1M (−4.13%)
Market closed. Prices as of Nov 20, 9:11 AM ET
- Value at quarter end (Q3 2026)
- $113M
- Change from Q2 2026
- −$4.2M (−3.56%)
- Positions
- 6 · 0 new, 0 sold out
- Filed
- Nov 13, 2026
Not counted in the ranking: none$11.6M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesHNGE 40.7%MQ 23.6%XMTR 13.6%CARG 5.98%MXCT 5.40%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| HNGE Hinge Health, Inc. | 450,000 | $48.6M | 40.7% | Reduced −11% |
| MQ Marqeta, Inc. | 1,713,295 | $28.1M | 23.6% | Unchanged |
| XMTR Xometry, Inc. | 145,969 | $16.3M | 13.6% | Reduced −19% |
| CARG CarGurus, Inc. | 220,000 | $7.1M | 5.98% | Reduced −37% |
| MXCT MaxCyte, Inc. | 5,043,356 | $6.5M | 5.40% | Unchanged |
| RXST RxSight, Inc. | 278,865 | $1.3M | 1.08% | Unchanged |